Bio-Pathological Markers for the Diagnosis and Therapy of Cancers, 3rd Edition
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 15 March 2025 | Viewed by 597
Special Issue Editor
Interests: neuropathology; surgical pathology; uveal melanoma; immunohistochemistry; dermatopathology; oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The search for biological factors that may have a prognostic value or act as predictors of therapeutic response still represents one of the hottest fields in human cancer research. Nevertheless, new immunohistochemical or molecular markers that can improve diagnostic accuracy in clinical practice and make it more reproducible are constantly being studied.
This Special Issue is devoted to the study of new diagnostic tools and prognostic/predictive factors in human neoplasms. Manuscripts in which this topic is approached by immunohistochemistry (IHC) as a first step are particularly welcome, but, being aware of the strengths and limits of IHC, the use of other methods (e.g., Western blot, FISH, or next-generation sequencing) is also encouraged.
Authors should demonstrate the impact of their findings in their works in combination with the morphological evaluation of histologic samples.
Clinicopathological studies, in vitro and in vivo studies with cell culture and animals, and manuscripts in which immunohistochemical findings are supported by molecular ones are particularly welcome. A limited number of relevant case reports will also be considered for publication.
Dr. Giuseppe Broggi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prognostic and predictive factors
- cancer
- immunohistochemistry
- molecular biology
- cellular markers
- diagnosis
- immunomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
